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Introduction 
Array Comparative Genomic Hybridization (aCGH) with genome-wide coverage has 
proved to be valuable for postnatal and prenatal studies. Traditionally, prenatal 
diagnosis of chromosomal abnormalities has relied on conventional cytogenetics 
which required cell culture and chromosome analysis under microscope. 
 
Objectives 
To evaluate the use of aCGH for prenatal diagnosis in Hong Kong by comparing the (1) 
concordance of results and (2) reporting time against that of conventional 
cytogenetics. 
 
Methodology 
Two hundred and fifty-two prenatal samples (mostly amniotic fluid or chorionic villi) 
were analysed by both NimbleGen whole genome oligo array CGX-12 with 135K oligo 
probes/array as well as conventional karyotyping from January 2011 to December 
2011 in Tsan Yuk Hospital Prenatal Diagnostic Laboratory. The proportion of cases 
detected with clinically significant copy number variations (CNVs) by aCGH were 
compared to abnormal karyotypes by conventional cytogenetics. 
 
Result 
Clinically significant CNVs were detected in 42 (16.7%) out of 252 samples. 12 
abnormalities (4.8%) were not detected by conventional karyotyping. Among 106 
samples with ultrasound abnormalities, clinically significant CNVs were detected in 36 
(34%). 12 abnormalities (11.3%) were not detected by conventional karyotyping. 
These additionally diagnosed cases include complex unbalanced rearrangements 
and microdeletions which are clinically important and relevant for counselling on 
future reproductive risks. Array CGH also enhanced the characterization of the origin 
and genetic content of supernumerary marker chromosomes. The reporting time has 
shortened from 14 days for karyotyping to around 5 days for aCGH initial reporting. 
Conclusion: Array CGH is a promising prenatal diagnostic test with improved 
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diagnostic yield and shortened reporting time by 64%. 
